ZENTALIS PHARMACEUTICA

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

14 مايو 2025 13:05:01 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 مايو 2025 14:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

28 أبريل 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

23 أبريل 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أبريل 2025 14:30:34 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

26 مارس 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

25 مارس 2025 13:40:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

15 مارس 2025 08:25:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 مارس 2025 14:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

03 مارس 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

24 فبراير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03 فبراير 2025 14:42:06 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

29 يناير 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

28 يناير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies

09 يناير 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 يناير 2025 13:53:30 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Key Management Appointments

12 ديسمبر 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 ديسمبر 2024 13:35:10 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib

13 نوفمبر 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 نوفمبر 2024 16:04:44 بحسب Nasdaq GlobeNewswire